C

Cardiol Therapeutics Inc.

23 employees

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Basic info

Industry

biotechnology research

Sectors

Heart
Pericarditis
Biotechnology
Research
Drug Delivery
Heart Disease
Myocarditis
Formulation
Clinical-stage
Therapeutics
Heart Failure
Nanotechnology
Life Science

Date founded

2017

Funding rounds raised

Total raised

$17M

from 4 investors over 4 rounds

C

Cardiol Therapeutics Inc. raised $17M on May 13, 2020

Investors: Echelon Wealth Partners, AlbaCore Capital Group, Raymond James and Canaccord Financial

FAQ